Entity: HHS - Food and Drug Administration

News Roundup: The Post-Impeachment Purge and the Knock of Authoritarianism

February 21, 2020
If news about White House complacency in the face of foreign election interference doesn’t get your attention, here are some other items for your consideration.

FOIA to Multiple Agencies Requesting Communications About OSHA’s study of Johnson & Johnson Baby Powder

February 20, 2020
FOIA to the Food and Drug Administration (FDA) and the Department of Labor (DOL) requesting communications about OSHA’s study of Johnson & Johnson baby powder, which confirmed previous study’s findings of the presence of asbestos in the powder.

FOIA to Multiple Agencies Requesting OSHA’s study of Johnson & Johnson Baby Powder

February 20, 2020
FOIA to Food and Drug Administration (FDA) and the Department of Labor (DOL)requesting OSHA’s study of Johnson & Johnson baby powder, which confirmed previous study’s findings of the presence of asbestos in the powder.

News Roundup: Beyond Impeachment — The Investigations Continue

December 20, 2019
There's plenty to investigate as we approach the end of 2019 — Ukraine-related and otherwise.

FOIA to FDA Seeking Communications Between Acting Commissioner Giroir and AlloVir

December 19, 2019
FOIA to Health and Human Services seeking communications and meeting records between Acting Commissioner Brett Giroir and representatives of his prior employer, AlloVir (formerly known as ViraCyte).

No Records Response from FDA Center for Tobacco Products Regarding Communications with Ballard Partners

September 25, 2019
The Center for Tobacco Products at the Food and Drug Administration stated that it had no records of communications with Ballard Partners. American Oversight filed this request following reporting indicating that this firm established its prominent position through its connections to the Trump administration.

News Roundup: Trump’s Enthusiastic Support for New Drug Raises Questions

September 6, 2019
Investigating the administration's approval of Spravato, Trump's potential campaign-finance violations, and the promotion of Trump properties.
(Photo: Gage Skidmore)

FOIA to FDA Seeking Email Communications Between FDA Officials and Mar-a-Lago Trio

September 4, 2019
FOIA request to the U.S. Food & Drug Administration seeking email communications between FDA officials and the Mar-a-Lago Trio regarding the anti-depressant nasal spray Spravato (esketamine).

FOIA to USDA for Records of Secretary Perdue Meetings

August 28, 2019
FOIA to the U.S. Department of Agriculture for records of certain 2017 meetings attended by Secretary Sonny Perdue.

News Roundup: Mueller Speaks

July 26, 2019
Special Counsel Robert Mueller made his long-awaited and much-anticipated appearance before Congress on Wednesday.